首页> 外国专利> As160 type Protein, Test Systems, and their use in Methods for the identification of Therapies for Type 2 diabetes

As160 type Protein, Test Systems, and their use in Methods for the identification of Therapies for Type 2 diabetes

机译:As160型蛋白,测试系统及其在2型糖尿病治疗方法鉴定中的用途

摘要

Similar to the substrate Protein of 160 kDa protein kinase AKT (Protein as160 type)A method for identifying a substance that Alters the uptake of glucose and / or translocation of GLUT4 to the plasma membrane of a cell that comprises contacting a Test System, which includes the like Protein of 160 kDa substrate of AKT (Protein such as 160) with u The test substance,And identify the test substance as a substance that Alters glucose uptake of a cell through the detection of a signal that indicates an alteration of glucose uptake of the cell; a test system comprising a Gene that encodes a Protein similar to the deducted AKT to 160 (160 kDa Protein as type) and an inducible Promoter that provides the expressionTrolable Gene; use of the test system for the identification of a substance that enhances glucose uptake and / or translocation of GLUT4 to the plasma membrane of a cell; and use of the 160 type Protein as a model for Type 2 diabetes.
机译:类似于底物160 kDa蛋白激酶AKT(Protein as160型)一种识别物质的方法,该物质可改变葡萄糖的摄取和GLUT4向细胞质膜的转运,包括与测试系统接触,包括与待测物质一起的AKT的160 kDa底物的类似蛋白质(如160等蛋白质),并通过检测指示葡萄糖摄取发生变化的信号来鉴定该受试物质为改变细胞葡萄糖摄取的物质细胞的一种测试系统,其包含编码与推定的AKT相似的蛋白质至160的蛋白质(160kDa蛋白质为类型)的基因和提供表达可转基因的诱导型启动子;该测试系统用于鉴定增强葡萄糖摄取和/或GLUT4向细胞质膜转运的物质; 160型蛋白质作为2型糖尿病模型的用途。

著录项

  • 公开/公告号AR067734A1

    专利类型

  • 公开/公告日2009-10-21

    原文格式PDF

  • 申请/专利权人 LIAO WENHUI;

    申请/专利号AR2008P103288

  • 发明设计人

    申请日2008-07-30

  • 分类号G01N33/68;C12N15/85;C12N15/12;C12N5/10;C12N15/11;C07K14/435;C07K16/18;C12Q1/68;

  • 国家 AR

  • 入库时间 2022-08-21 19:28:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号